tradingkey.logo
搜尋

Galecto Ord Shs

DMRA
添加自選
21.600USD
-0.450-2.04%
收盤 11-13 16:00(美東)
1.33B總市值
虧損本益比TTM

關於 Galecto Ord Shs 公司

Galecto, Inc. is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. It is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

Galecto Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Galecto Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--

常見問題

Galecto Ord Shs的前五大股東是誰?

Galecto Ord Shs的前五大股東如下:Mr. Sherwin Sattarzadeh
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有